Literature DB >> 10451161

Chronic sternal wound infection and endocarditis with Coxiella burnetii.

M Ghassemi1, W A Agger, R E Vanscoy, G B Howe.   

Abstract

Chronic Q fever is most commonly associated with culture-negative endocarditis and less frequently with infection of vascular grafts, infection of aneurysms, hepatitis, pulmonary disease, osteomyelitis, and neurological abnormalities. We report a case of chronic sternal wound infection, polyclonal gammopathy, and mixed cryoglobulinemia in which Q fever endocarditis was subsequently diagnosed. Polymerase chain reaction analysis of the wound tissue was positive for Coxiella burnetii DNA, and treatment of the endocarditis resulted in prompt healing of the wound. Chronic Q fever can occur without epidemiological risk factors for C. burnetii exposure and can produce multisystem inflammatory dysfunction, aberrations of the immune system, and persistent wound infections.

Entities:  

Mesh:

Year:  1999        PMID: 10451161     DOI: 10.1086/514797

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  [Diagnosis and follow-up management of postoperative bacterial osteitis].

Authors:  U Flückiger; W Zimmerli
Journal:  Orthopade       Date:  2004-04       Impact factor: 1.087

2.  Diagnosis of Coxiella burnetii infection via metagenomic next-generation sequencing: a case report.

Authors:  Jingjia Zhang; Yan Hao; Zhi Wang; Qiwen Yang
Journal:  BMC Infect Dis       Date:  2022-04-13       Impact factor: 3.090

Review 3.  Q fever endocarditis masquerading as Mixed cryoglobulinemia type II. A case report and review of the literature.

Authors:  Petros I Rafailidis; Spiros P Dourakis; Christos A Fourlas
Journal:  BMC Infect Dis       Date:  2006-02-23       Impact factor: 3.090

4.  The first case of chronic Q fever endocarditis and aortitis from Turkey: A 5-year infection before diagnosis with drain in sternum.

Authors:  Serap Şimşek Yavuz; Ezgi Özbek; Seniha Başaran; Bekir Çelebi; Ebru Yılmaz; Murat Başaran; Berrin Umman; Haluk Eraksoy
Journal:  Anatol J Cardiol       Date:  2016-10       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.